APO Research
Talk to an analyst

APO RESEARCH · REPORT

Pharmaceutical Impurity Analysis Service

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Pharmaceutical Impurity Analysis Service Market Outlook and Growth Opportunities 2026

1 January 2026193 pages

Choose your research edition.

Industry ResearchPharmaceutical Impurity Analysis Service Industry Research Report 2026134 pages · $2,950 USDIndustry Growth & TrendsGlobal Pharmaceutical Impurity Analysis Service Industry Growth and Trends Forecast to 2032111 pages · $3,450 USDMarket StructureGlobal Pharmaceutical Impurity Analysis Service Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032191 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Pharmaceutical Impurity Analysis Service Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal Pharmaceutical Impurity Analysis Service Market Analysis and Forecast 2026-2032192 pages · $4,950 USD

Market perspective

The global Pharmaceutical Impurity Analysis Service market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Pharmaceutical Impurity Analysis Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Pharmaceutical Impurity Analysis Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Pharmaceutical Impurity Analysis Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Pharmaceutical Impurity Analysis Service market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Pharmaceutical Impurity Analysis Service market include Intertek, Creative Proteomics, Emery Pharma, Agilent, Vimta, Alfa Chemistry, Eurofins, Alera Labs and Impact Analytical, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Pharmaceutical Impurity Analysis Service market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Pharmaceutical Impurity Analysis Service and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Pharmaceutical Impurity Analysis Service revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Pharmaceutical Impurity Analysis Service market.

Pharmaceutical Impurity Analysis Service Segment by Company

Intertek

Creative Proteomics

Emery Pharma

Agilent

Vimta

Alfa Chemistry

Eurofins

Alera Labs

Impact Analytical

Leeder Analytical

Nelson Labs

Reading Scientific Services

Regis Technologies

Selvita

SGS

Pharmaceutical Impurity Analysis Service Segment by Type

Organic Impurity Analysis

Inorganic Impurity Analysis

Residual Solvent Analysis

Others

Pharmaceutical Impurity Analysis Service Segment by Application

Pharmaceutical Industry

Agriculture

Biotechnology

Others

Pharmaceutical Impurity Analysis Service Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Pharmaceutical Impurity Analysis Service status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Pharmaceutical Impurity Analysis Service key companies, revenue, market share, and recent developments.

3. To split the Pharmaceutical Impurity Analysis Service breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Pharmaceutical Impurity Analysis Service market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Pharmaceutical Impurity Analysis Service significant trends, drivers, influence factors in global and regions.

6. To analyze Pharmaceutical Impurity Analysis Service competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pharmaceutical Impurity Analysis Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Pharmaceutical Impurity Analysis Service and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pharmaceutical Impurity Analysis Service.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Pharmaceutical Impurity Analysis Service industry.

Chapter 3: Detailed analysis of Pharmaceutical Impurity Analysis Service company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Pharmaceutical Impurity Analysis Service in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Pharmaceutical Impurity Analysis Service in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Pharmaceutical Impurity Analysis Service Industry Trends Table 2. Pharmaceutical Impurity Analysis Service Industry Drivers Table 3. Pharmaceutical Impurity Analysis Service Industry Opportunities and Challenges Table 4. Pharmaceutical Impurity Analysis Service Industry Restraints Table 5. Global Pharmaceutical Impurity Analysis Service Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Pharmaceutical Impurity Analysis Service Revenue Share by Company (2021-2026) Table 7. Global Pharmaceutical Impurity Analysis Service Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Pharmaceutical Impurity Analysis Service Key Company Manufacturing Base & Headquarters Table 9. Global Pharmaceutical Impurity Analysis Service Company, Product Type & Application Table 10. Global Pharmaceutical Impurity Analysis Service Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Pharmaceutical Impurity Analysis Service by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Organic Impurity Analysis Table 15. Significant Companies of Inorganic Impurity Analysis Table 16. Significant Companies of Residual Solvent Analysis Table 17. Significant Companies of Others Table 18. Global Pharmaceutical Impurity Analysis Service Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 19. Global Pharmaceutical Impurity Analysis Service Sales Value by Type (2021-2026) & (US$ Million) Table 20. Global Pharmaceutical Impurity Analysis Service Sales Value by Type (2027-2032) & (US$ Million) Table 21. Global Pharmaceutical Impurity Analysis Service Sales Value Share by Type (2021-2026) Table 22. Global Pharmaceutical Impurity Analysis Service Sales Value Share by Type (2027-2032) Table 23. Significant Companies of Pharmaceutical Industry Table 24. Significant Companies of Agriculture Table 25. Significant Companies of Biotechnology Table 26. Significant Companies of Others Table 27. Global Pharmaceutical Impurity Analysis Service Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 28. Global Pharmaceutical Impurity Analysis Service Sales Value by Application (2021-2026) & (US$ Million) Table 29. Global Pharmaceutical Impurity Analysis Service Sales Value by Application (2027-2032) & (US$ Million) Table 30. Global Pharmaceutical Impurity Analysis Service Sales Value Share by Application (2021-2026) Table 31. Global Pharmaceutical Impurity Analysis Service Sales Value Share by Application (2027-2032) Table 32. Global Pharmaceutical Impurity Analysis Service Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 33. Global Pharmaceutical Impurity Analysis Service Sales Value by Region (2021-2026) & (US$ Million) Table 34. Global Pharmaceutical Impurity Analysis Service Sales Value Share by Region (2021-2026) Table 35. Global Pharmaceutical Impurity Analysis Service Sales Value by Region (2027-2032) & (US$ Million) Table 36. Global Pharmaceutical Impurity Analysis Service Sales Value Share by Region (2027-2032) Table 37. Global Pharmaceutical Impurity Analysis Service Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 38. Global Pharmaceutical Impurity Analysis Service Sales Value by Country (2021-2026) & (US$ Million) Table 39. Global Pharmaceutical Impurity Analysis Service Sales Value Market Share by Country (2021-2026) Table 40. Global Pharmaceutical Impurity Analysis Service Sales Value by Country (2027-2032) & (US$ Million) Table 41. Global Pharmaceutical Impurity Analysis Service Sales Value Market Share by Country (2027-2032) Table 42. Intertek Company Information Table 43. Intertek Business Overview Table 44. Intertek Pharmaceutical Impurity Analysis Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 45. Intertek Pharmaceutical Impurity Analysis Service Product Portfolio Table 46. Intertek Recent Development Table 47. Creative Proteomics Company Information Table 48. Creative Proteomics Business Overview Table 49. Creative Proteomics Pharmaceutical Impurity Analysis Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 50. Creative Proteomics Pharmaceutical Impurity Analysis Service Product Portfolio Table 51. Creative Proteomics Recent Development Table 52. Emery Pharma Company Information Table 53. Emery Pharma Business Overview Table 54. Emery Pharma Pharmaceutical Impurity Analysis Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 55. Emery Pharma Pharmaceutical Impurity Analysis Service Product Portfolio Table 56. Emery Pharma Recent Development Table 57. Agilent Company Information Table 58. Agilent Business Overview Table 59. Agilent Pharmaceutical Impurity Analysis Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 60. Agilent Pharmaceutical Impurity Analysis Service Product Portfolio Table 61. Agilent Recent Development Table 62. Vimta Company Information Table 63. Vimta Business Overview Table 64. Vimta Pharmaceutical Impurity Analysis Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 65. Vimta Pharmaceutical Impurity Analysis Service Product Portfolio Table 66. Vimta Recent Development Table 67. Alfa Chemistry Company Information Table 68. Alfa Chemistry Business Overview Table 69. Alfa Chemistry Pharmaceutical Impurity Analysis Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 70. Alfa Chemistry Pharmaceutical Impurity Analysis Service Product Portfolio Table 71. Alfa Chemistry Recent Development Table 72. Eurofins Company Information Table 73. Eurofins Business Overview Table 74. Eurofins Pharmaceutical Impurity Analysis Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 75. Eurofins Pharmaceutical Impurity Analysis Service Product Portfolio Table 76. Eurofins Recent Development Table 77. Alera Labs Company Information Table 78. Alera Labs Business Overview Table 79. Alera Labs Pharmaceutical Impurity Analysis Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 80. Alera Labs Pharmaceutical Impurity Analysis Service Product Portfolio Table 81. Alera Labs Recent Development Table 82. Impact Analytical Company Information Table 83. Impact Analytical Business Overview Table 84. Impact Analytical Pharmaceutical Impurity Analysis Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 85. Impact Analytical Pharmaceutical Impurity Analysis Service Product Portfolio Table 86. Impact Analytical Recent Development Table 87. Leeder Analytical Company Information Table 88. Leeder Analytical Business Overview Table 89. Leeder Analytical Pharmaceutical Impurity Analysis Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 90. Leeder Analytical Pharmaceutical Impurity Analysis Service Product Portfolio Table 91. Leeder Analytical Recent Development Table 92. Nelson Labs Company Information Table 93. Nelson Labs Business Overview Table 94. Nelson Labs Pharmaceutical Impurity Analysis Service Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 95. Nelson Labs Pharmaceutical Impurity Analysis Service Product Portfolio Table 96. Nelson Labs Recent Development Table 97. Reading Scientific Services Company Information Table 98. Reading Scientific Services Business Overview Table 99. Reading Scientific Services Pharmaceutical Impurity Analysis Service Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 100. Reading Scientific Services Pharmaceutical Impurity Analysis Service Product Portfolio Table 101. Reading Scientific Services Recent Development Table 102. Regis Technologies Company Information Table 103. Regis Technologies Business Overview Table 104. Regis Technologies Pharmaceutical Impurity Analysis Service Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 105. Regis Technologies Pharmaceutical Impurity Analysis Service Product Portfolio Table 106. Regis Technologies Recent Development Table 107. Selvita Company Information Table 108. Selvita Business Overview Table 109. Selvita Pharmaceutical Impurity Analysis Service Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 110. Selvita Pharmaceutical Impurity Analysis Service Product Portfolio Table 111. Selvita Recent Development Table 112. SGS Company Information Table 113. SGS Business Overview Table 114. SGS Pharmaceutical Impurity Analysis Service Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 115. SGS Pharmaceutical Impurity Analysis Service Product Portfolio Table 116. SGS Recent Development Table 117. Research Programs/Design for This Report Table 118. Authors List of This Report Table 119. Secondary Sources Table 120. Primary Sources List of Figures Figure 1. Pharmaceutical Impurity Analysis Service Product Image Figure 2. Global Pharmaceutical Impurity Analysis Service Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Pharmaceutical Impurity Analysis Service Market Size (2021-2032) & (US$ Million) Figure 4. Global Pharmaceutical Impurity Analysis Service Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Organic Impurity Analysis Image Figure 8. Inorganic Impurity Analysis Image Figure 9. Residual Solvent Analysis Image Figure 10. Others Image Figure 11. Global Pharmaceutical Impurity Analysis Service Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 12. Global Pharmaceutical Impurity Analysis Service Sales Value Share 2021 VS 2025 VS 2032 Figure 13. Global Pharmaceutical Impurity Analysis Service Sales Value Share by Type (2021-2032) Figure 14. Pharmaceutical Industry Image Figure 15. Agriculture Image Figure 16. Biotechnology Image Figure 17. Others Image Figure 18. Global Pharmaceutical Impurity Analysis Service Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 19. Global Pharmaceutical Impurity Analysis Service Sales Value Share 2021 VS 2025 VS 2032 Figure 20. Global Pharmaceutical Impurity Analysis Service Sales Value Share by Application (2021-2032) Figure 21. Global Pharmaceutical Impurity Analysis Service Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 22. Global Pharmaceutical Impurity Analysis Service Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 23. North America Pharmaceutical Impurity Analysis Service Sales Value (2021-2032) & (US$ Million) Figure 24. North America Pharmaceutical Impurity Analysis Service Sales Value Share by Country (%), 2025 VS 2032 Figure 25. Europe Pharmaceutical Impurity Analysis Service Sales Value (2021-2032) & (US$ Million) Figure 26. Europe Pharmaceutical Impurity Analysis Service Sales Value Share by Country (%), 2025 VS 2032 Figure 27. Asia-Pacific Pharmaceutical Impurity Analysis Service Sales Value (2021-2032) & (US$ Million) Figure 28. Asia-Pacific Pharmaceutical Impurity Analysis Service Sales Value Share by Country (%), 2025 VS 2032 Figure 29. South America Pharmaceutical Impurity Analysis Service Sales Value (2021-2032) & (US$ Million) Figure 30. South America Pharmaceutical Impurity Analysis Service Sales Value Share by Country (%), 2025 VS 2032 Figure 31. Middle East & Africa Pharmaceutical Impurity Analysis Service Sales Value (2021-2032) & (US$ Million) Figure 32. Middle East & Africa Pharmaceutical Impurity Analysis Service Sales Value Share by Country (%), 2025 VS 2032 Figure 33. USA Pharmaceutical Impurity Analysis Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 34. USA Pharmaceutical Impurity Analysis Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 35. USA Pharmaceutical Impurity Analysis Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 36. Canada Pharmaceutical Impurity Analysis Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 37. Canada Pharmaceutical Impurity Analysis Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 38. Canada Pharmaceutical Impurity Analysis Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 39. Mexico Pharmaceutical Impurity Analysis Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 40. Mexico Pharmaceutical Impurity Analysis Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 41. Mexico Pharmaceutical Impurity Analysis Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 42. Germany Pharmaceutical Impurity Analysis Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. Germany Pharmaceutical Impurity Analysis Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. Germany Pharmaceutical Impurity Analysis Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. France Pharmaceutical Impurity Analysis Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. France Pharmaceutical Impurity Analysis Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. France Pharmaceutical Impurity Analysis Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. U.K. Pharmaceutical Impurity Analysis Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. U.K. Pharmaceutical Impurity Analysis Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. U.K. Pharmaceutical Impurity Analysis Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. Italy Pharmaceutical Impurity Analysis Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. Italy Pharmaceutical Impurity Analysis Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. Italy Pharmaceutical Impurity Analysis Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. Spain Pharmaceutical Impurity Analysis Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. Spain Pharmaceutical Impurity Analysis Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. Spain Pharmaceutical Impurity Analysis Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. Russia Pharmaceutical Impurity Analysis Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. Russia Pharmaceutical Impurity Analysis Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. Russia Pharmaceutical Impurity Analysis Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Netherlands Pharmaceutical Impurity Analysis Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Netherlands Pharmaceutical Impurity Analysis Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Netherlands Pharmaceutical Impurity Analysis Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. Nordic Countries Pharmaceutical Impurity Analysis Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. Nordic Countries Pharmaceutical Impurity Analysis Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. Nordic Countries Pharmaceutical Impurity Analysis Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. China Pharmaceutical Impurity Analysis Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. China Pharmaceutical Impurity Analysis Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. China Pharmaceutical Impurity Analysis Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. Japan Pharmaceutical Impurity Analysis Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. Japan Pharmaceutical Impurity Analysis Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. Japan Pharmaceutical Impurity Analysis Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. South Korea Pharmaceutical Impurity Analysis Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. South Korea Pharmaceutical Impurity Analysis Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. South Korea Pharmaceutical Impurity Analysis Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. India Pharmaceutical Impurity Analysis Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. India Pharmaceutical Impurity Analysis Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. India Pharmaceutical Impurity Analysis Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. Australia Pharmaceutical Impurity Analysis Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. Australia Pharmaceutical Impurity Analysis Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. Australia Pharmaceutical Impurity Analysis Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. Southeast Asia Pharmaceutical Impurity Analysis Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. Southeast Asia Pharmaceutical Impurity Analysis Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. Southeast Asia Pharmaceutical Impurity Analysis Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. Brazil Pharmaceutical Impurity Analysis Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. Brazil Pharmaceutical Impurity Analysis Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. Brazil Pharmaceutical Impurity Analysis Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Argentina Pharmaceutical Impurity Analysis Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Argentina Pharmaceutical Impurity Analysis Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Argentina Pharmaceutical Impurity Analysis Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Chile Pharmaceutical Impurity Analysis Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Chile Pharmaceutical Impurity Analysis Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Chile Pharmaceutical Impurity Analysis Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Colombia Pharmaceutical Impurity Analysis Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Colombia Pharmaceutical Impurity Analysis Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Colombia Pharmaceutical Impurity Analysis Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Peru Pharmaceutical Impurity Analysis Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Peru Pharmaceutical Impurity Analysis Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Peru Pharmaceutical Impurity Analysis Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Saudi Arabia Pharmaceutical Impurity Analysis Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Saudi Arabia Pharmaceutical Impurity Analysis Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Saudi Arabia Pharmaceutical Impurity Analysis Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. Israel Pharmaceutical Impurity Analysis Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. Israel Pharmaceutical Impurity Analysis Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. Israel Pharmaceutical Impurity Analysis Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. UAE Pharmaceutical Impurity Analysis Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. UAE Pharmaceutical Impurity Analysis Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. UAE Pharmaceutical Impurity Analysis Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Turkey Pharmaceutical Impurity Analysis Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Turkey Pharmaceutical Impurity Analysis Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Turkey Pharmaceutical Impurity Analysis Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. Iran Pharmaceutical Impurity Analysis Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. Iran Pharmaceutical Impurity Analysis Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. Iran Pharmaceutical Impurity Analysis Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. Egypt Pharmaceutical Impurity Analysis Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 115. Egypt Pharmaceutical Impurity Analysis Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 116. Egypt Pharmaceutical Impurity Analysis Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 117. Years Considered Figure 118. Research Process Figure 119. Key Executives Interviewed

Scope & coverage.

Types
  • Organic Impurity Analysis
  • Inorganic Impurity Analysis
  • Residual Solvent Analysis
  • Others
Applications
  • Pharmaceutical Industry
  • Agriculture
  • Biotechnology
  • Others
Companies covered
  • Intertek
  • Creative Proteomics
  • Emery Pharma
  • Agilent
  • Vimta
  • Alfa Chemistry
  • Eurofins
  • Alera Labs
  • Impact Analytical
  • Leeder Analytical
  • Nelson Labs
  • Reading Scientific Services
  • Regis Technologies
  • Selvita
  • SGS

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Pharmaceutical Impurity Analysis Service Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Pharmaceutical Impurity Analysis Service Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Pharmaceutical Impurity Analysis Service Market Dynamics
  1. 2.1 Pharmaceutical Impurity Analysis Service Industry Trends
  2. 2.2 Pharmaceutical Impurity Analysis Service Industry Drivers
  3. 2.3 Pharmaceutical Impurity Analysis Service Industry Opportunities and Challenges
  4. 2.4 Pharmaceutical Impurity Analysis Service Industry Restraints
3 Pharmaceutical Impurity Analysis Service Market by Company
  1. 3.1 Global Pharmaceutical Impurity Analysis Service Company Revenue Ranking in 2025
  2. 3.2 Global Pharmaceutical Impurity Analysis Service Revenue by Company (2021-2026)
  3. 3.3 Global Pharmaceutical Impurity Analysis Service Company Ranking (2024-2026)
  4. 3.4 Global Pharmaceutical Impurity Analysis Service Company Manufacturing Base and Headquarters
  5. 3.5 Global Pharmaceutical Impurity Analysis Service Company Product Type and Application
  6. 3.6 Global Pharmaceutical Impurity Analysis Service Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Pharmaceutical Impurity Analysis Service Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Pharmaceutical Impurity Analysis Service Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Pharmaceutical Impurity Analysis Service Market by Type
  1. 4.1 Pharmaceutical Impurity Analysis Service Type Introduction
  2. 4.1.1 Organic Impurity Analysis
  3. 4.1.2 Inorganic Impurity Analysis
  4. 4.1.3 Residual Solvent Analysis
  5. 4.1.4 Others
  6. 4.2 Global Pharmaceutical Impurity Analysis Service Sales Value by Type
  7. 4.2.1 Global Pharmaceutical Impurity Analysis Service Sales Value by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global Pharmaceutical Impurity Analysis Service Sales Value by Type (2021-2032)
  9. 4.2.3 Global Pharmaceutical Impurity Analysis Service Sales Value Share by Type (2021-2032)
5 Pharmaceutical Impurity Analysis Service Market by Application
  1. 5.1 Pharmaceutical Impurity Analysis Service Application Introduction
  2. 5.1.1 Pharmaceutical Industry
  3. 5.1.2 Agriculture
  4. 5.1.3 Biotechnology
  5. 5.1.4 Others
  6. 5.2 Global Pharmaceutical Impurity Analysis Service Sales Value by Application
  7. 5.2.1 Global Pharmaceutical Impurity Analysis Service Sales Value by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Pharmaceutical Impurity Analysis Service Sales Value by Application (2021-2032)
  9. 5.2.3 Global Pharmaceutical Impurity Analysis Service Sales Value Share by Application (2021-2032)
6 Pharmaceutical Impurity Analysis Service Regional Value Analysis
  1. 6.1 Global Pharmaceutical Impurity Analysis Service Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Pharmaceutical Impurity Analysis Service Sales Value by Region (2021-2032)
  3. 6.2.1 Global Pharmaceutical Impurity Analysis Service Sales Value by Region: 2021-2026
  4. 6.2.2 Global Pharmaceutical Impurity Analysis Service Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Pharmaceutical Impurity Analysis Service Sales Value (2021-2032)
  7. 6.3.2 North America Pharmaceutical Impurity Analysis Service Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Pharmaceutical Impurity Analysis Service Sales Value (2021-2032)
  10. 6.4.2 Europe Pharmaceutical Impurity Analysis Service Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Pharmaceutical Impurity Analysis Service Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Pharmaceutical Impurity Analysis Service Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Pharmaceutical Impurity Analysis Service Sales Value (2021-2032)
  16. 6.6.2 South America Pharmaceutical Impurity Analysis Service Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Pharmaceutical Impurity Analysis Service Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Pharmaceutical Impurity Analysis Service Sales Value Share by Country, 2025 VS 2032
7 Pharmaceutical Impurity Analysis Service Country-level Value Analysis
  1. 7.1 Global Pharmaceutical Impurity Analysis Service Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Pharmaceutical Impurity Analysis Service Sales Value by Country (2021-2032)
  3. 7.2.1 Global Pharmaceutical Impurity Analysis Service Sales Value by Country (2021-2026)
  4. 7.2.2 Global Pharmaceutical Impurity Analysis Service Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Pharmaceutical Impurity Analysis Service Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Pharmaceutical Impurity Analysis Service Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Pharmaceutical Impurity Analysis Service Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Pharmaceutical Impurity Analysis Service Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Pharmaceutical Impurity Analysis Service Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Pharmaceutical Impurity Analysis Service Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Pharmaceutical Impurity Analysis Service Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Pharmaceutical Impurity Analysis Service Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Pharmaceutical Impurity Analysis Service Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Pharmaceutical Impurity Analysis Service Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Pharmaceutical Impurity Analysis Service Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Pharmaceutical Impurity Analysis Service Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Pharmaceutical Impurity Analysis Service Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Pharmaceutical Impurity Analysis Service Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Pharmaceutical Impurity Analysis Service Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Pharmaceutical Impurity Analysis Service Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Pharmaceutical Impurity Analysis Service Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Pharmaceutical Impurity Analysis Service Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Pharmaceutical Impurity Analysis Service Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Pharmaceutical Impurity Analysis Service Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Pharmaceutical Impurity Analysis Service Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Pharmaceutical Impurity Analysis Service Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Pharmaceutical Impurity Analysis Service Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Pharmaceutical Impurity Analysis Service Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Pharmaceutical Impurity Analysis Service Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Pharmaceutical Impurity Analysis Service Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Pharmaceutical Impurity Analysis Service Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Pharmaceutical Impurity Analysis Service Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Pharmaceutical Impurity Analysis Service Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Pharmaceutical Impurity Analysis Service Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Pharmaceutical Impurity Analysis Service Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Pharmaceutical Impurity Analysis Service Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Pharmaceutical Impurity Analysis Service Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Pharmaceutical Impurity Analysis Service Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Pharmaceutical Impurity Analysis Service Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Pharmaceutical Impurity Analysis Service Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Pharmaceutical Impurity Analysis Service Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Pharmaceutical Impurity Analysis Service Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Pharmaceutical Impurity Analysis Service Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Pharmaceutical Impurity Analysis Service Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Pharmaceutical Impurity Analysis Service Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Pharmaceutical Impurity Analysis Service Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Pharmaceutical Impurity Analysis Service Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Pharmaceutical Impurity Analysis Service Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Pharmaceutical Impurity Analysis Service Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Pharmaceutical Impurity Analysis Service Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Pharmaceutical Impurity Analysis Service Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Pharmaceutical Impurity Analysis Service Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Pharmaceutical Impurity Analysis Service Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Pharmaceutical Impurity Analysis Service Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Pharmaceutical Impurity Analysis Service Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Pharmaceutical Impurity Analysis Service Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Pharmaceutical Impurity Analysis Service Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Pharmaceutical Impurity Analysis Service Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Pharmaceutical Impurity Analysis Service Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Pharmaceutical Impurity Analysis Service Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Pharmaceutical Impurity Analysis Service Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Pharmaceutical Impurity Analysis Service Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Pharmaceutical Impurity Analysis Service Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Pharmaceutical Impurity Analysis Service Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Pharmaceutical Impurity Analysis Service Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Pharmaceutical Impurity Analysis Service Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Pharmaceutical Impurity Analysis Service Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Pharmaceutical Impurity Analysis Service Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Pharmaceutical Impurity Analysis Service Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Pharmaceutical Impurity Analysis Service Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Pharmaceutical Impurity Analysis Service Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Pharmaceutical Impurity Analysis Service Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Pharmaceutical Impurity Analysis Service Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Pharmaceutical Impurity Analysis Service Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Pharmaceutical Impurity Analysis Service Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Pharmaceutical Impurity Analysis Service Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Pharmaceutical Impurity Analysis Service Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Pharmaceutical Impurity Analysis Service Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Pharmaceutical Impurity Analysis Service Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Pharmaceutical Impurity Analysis Service Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Pharmaceutical Impurity Analysis Service Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Pharmaceutical Impurity Analysis Service Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Pharmaceutical Impurity Analysis Service Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Pharmaceutical Impurity Analysis Service Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Pharmaceutical Impurity Analysis Service Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Pharmaceutical Impurity Analysis Service Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Pharmaceutical Impurity Analysis Service Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Pharmaceutical Impurity Analysis Service Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Intertek
  2. 8.1.1 Intertek Company Information
  3. 8.1.2 Intertek Business Overview
  4. 8.1.3 Intertek Pharmaceutical Impurity Analysis Service Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Intertek Pharmaceutical Impurity Analysis Service Product Portfolio
  6. 8.1.5 Intertek Recent Developments
  7. 8.2 Creative Proteomics
  8. 8.2.1 Creative Proteomics Company Information
  9. 8.2.2 Creative Proteomics Business Overview
  10. 8.2.3 Creative Proteomics Pharmaceutical Impurity Analysis Service Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Creative Proteomics Pharmaceutical Impurity Analysis Service Product Portfolio
  12. 8.2.5 Creative Proteomics Recent Developments
  13. 8.3 Emery Pharma
  14. 8.3.1 Emery Pharma Company Information
  15. 8.3.2 Emery Pharma Business Overview
  16. 8.3.3 Emery Pharma Pharmaceutical Impurity Analysis Service Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Emery Pharma Pharmaceutical Impurity Analysis Service Product Portfolio
  18. 8.3.5 Emery Pharma Recent Developments
  19. 8.4 Agilent
  20. 8.4.1 Agilent Company Information
  21. 8.4.2 Agilent Business Overview
  22. 8.4.3 Agilent Pharmaceutical Impurity Analysis Service Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Agilent Pharmaceutical Impurity Analysis Service Product Portfolio
  24. 8.4.5 Agilent Recent Developments
  25. 8.5 Vimta
  26. 8.5.1 Vimta Company Information
  27. 8.5.2 Vimta Business Overview
  28. 8.5.3 Vimta Pharmaceutical Impurity Analysis Service Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Vimta Pharmaceutical Impurity Analysis Service Product Portfolio
  30. 8.5.5 Vimta Recent Developments
  31. 8.6 Alfa Chemistry
  32. 8.6.1 Alfa Chemistry Company Information
  33. 8.6.2 Alfa Chemistry Business Overview
  34. 8.6.3 Alfa Chemistry Pharmaceutical Impurity Analysis Service Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Alfa Chemistry Pharmaceutical Impurity Analysis Service Product Portfolio
  36. 8.6.5 Alfa Chemistry Recent Developments
  37. 8.7 Eurofins
  38. 8.7.1 Eurofins Company Information
  39. 8.7.2 Eurofins Business Overview
  40. 8.7.3 Eurofins Pharmaceutical Impurity Analysis Service Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Eurofins Pharmaceutical Impurity Analysis Service Product Portfolio
  42. 8.7.5 Eurofins Recent Developments
  43. 8.8 Alera Labs
  44. 8.8.1 Alera Labs Company Information
  45. 8.8.2 Alera Labs Business Overview
  46. 8.8.3 Alera Labs Pharmaceutical Impurity Analysis Service Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Alera Labs Pharmaceutical Impurity Analysis Service Product Portfolio
  48. 8.8.5 Alera Labs Recent Developments
  49. 8.9 Impact Analytical
  50. 8.9.1 Impact Analytical Company Information
  51. 8.9.2 Impact Analytical Business Overview
  52. 8.9.3 Impact Analytical Pharmaceutical Impurity Analysis Service Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Impact Analytical Pharmaceutical Impurity Analysis Service Product Portfolio
  54. 8.9.5 Impact Analytical Recent Developments
  55. 8.10 Leeder Analytical
  56. 8.10.1 Leeder Analytical Company Information
  57. 8.10.2 Leeder Analytical Business Overview
  58. 8.10.3 Leeder Analytical Pharmaceutical Impurity Analysis Service Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Leeder Analytical Pharmaceutical Impurity Analysis Service Product Portfolio
  60. 8.10.5 Leeder Analytical Recent Developments
  61. 8.11 Nelson Labs
  62. 8.11.1 Nelson Labs Company Information
  63. 8.11.2 Nelson Labs Business Overview
  64. 8.11.3 Nelson Labs Pharmaceutical Impurity Analysis Service Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Nelson Labs Pharmaceutical Impurity Analysis Service Product Portfolio
  66. 8.11.5 Nelson Labs Recent Developments
  67. 8.12 Reading Scientific Services
  68. 8.12.1 Reading Scientific Services Company Information
  69. 8.12.2 Reading Scientific Services Business Overview
  70. 8.12.3 Reading Scientific Services Pharmaceutical Impurity Analysis Service Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Reading Scientific Services Pharmaceutical Impurity Analysis Service Product Portfolio
  72. 8.12.5 Reading Scientific Services Recent Developments
  73. 8.13 Regis Technologies
  74. 8.13.1 Regis Technologies Company Information
  75. 8.13.2 Regis Technologies Business Overview
  76. 8.13.3 Regis Technologies Pharmaceutical Impurity Analysis Service Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Regis Technologies Pharmaceutical Impurity Analysis Service Product Portfolio
  78. 8.13.5 Regis Technologies Recent Developments
  79. 8.14 Selvita
  80. 8.14.1 Selvita Company Information
  81. 8.14.2 Selvita Business Overview
  82. 8.14.3 Selvita Pharmaceutical Impurity Analysis Service Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Selvita Pharmaceutical Impurity Analysis Service Product Portfolio
  84. 8.14.5 Selvita Recent Developments
  85. 8.15 SGS
  86. 8.15.1 SGS Company Information
  87. 8.15.2 SGS Business Overview
  88. 8.15.3 SGS Pharmaceutical Impurity Analysis Service Revenue and Gross Margin (2021-2026)
  89. 8.15.4 SGS Pharmaceutical Impurity Analysis Service Product Portfolio
  90. 8.15.5 SGS Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst